Organon (OGN) Shares Outstanding (Entity) (2020 - 2026)
Organon (OGN) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 1.90 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 262.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 262.61 Mn |
| Mar 31, 2026 | 262.65 Mn |
| Dec 31, 2025 | 260.32 Mn |
| Sep 30, 2025 | 259.98 Mn |
| Jun 30, 2025 | 259.97 Mn |
| Mar 31, 2025 | 257.95 Mn |
| Dec 31, 2024 | 257.80 Mn |
| Sep 30, 2024 | 257.54 Mn |
| Jun 30, 2024 | 257.47 Mn |
| Mar 31, 2024 | 255.85 Mn |
| Dec 31, 2023 | 255.63 Mn |
| Sep 30, 2023 | 255.61 Mn |
| Jun 30, 2023 | 255.57 Mn |
| Mar 31, 2023 | 254.43 Mn |
| Dec 31, 2022 | 254.37 Mn |
| Sep 30, 2022 | 254.36 Mn |
| Jun 30, 2022 | 254.32 Mn |
| Mar 31, 2022 | 253.64 Mn |
| Dec 31, 2021 | 253.55 Mn |
| Sep 30, 2021 | 253.55 Mn |